Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00222937 · ClinicalTrials.gov registry record · Phase 3

Voice Therapy for Teachers With Voice Problems

A Phase 3 study, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 3
Development phase
105
Enrollment target

NCT00222937 is a Phase 3 study that has completed, run by University of Pittsburgh. The registered enrollment target is 105 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00222937, a Phase 3 study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 3
Development phase
105 participants
Enrollment target

Study Summary

The study compares two different forms of voice therapy, Lessac-Madsen Resonant Voice Therapy and Casper-Based Confidential Flow Therapy. The target population are teachers because they have the highest risk for developing voice problems. For this study the investigators are primarily interested in seeing if Lessac-Madsen Resonant Voice Therapy (LMRVT) and Casper-Based Confidential Flow Therapy (CBCFT) are equally effective at improving vocal functioning in teachers with phonotrauma, as assessed by the Voice Handicap Index (VHI).

Interventions

  • BEHAVIORAL Lessac-Madsen Resonant Voice Therapy
  • BEHAVIORAL Casper-Based Confidential Flow Therapy

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2005-10
Est. Completion 2010-08
Phase Phase 3

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00222937

The ClinicalTrials.gov registry entry for NCT00222937 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Lessac-Madsen Resonant Voice Therapy is the first listed.

NCT00222937 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00222937 about?

NCT00222937 is a clinical study titled "Voice Therapy for Teachers With Voice Problems". The study compares two different forms of voice therapy, Lessac-Madsen Resonant Voice Therapy and Casper-Based Confidential Flow Therapy. The target population are teachers because they have the highest risk for developing voice problems. For this study the investigators are primarily interested in ...

What is the current status of trial NCT00222937?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 105 participants. The study started on 2005-10. Estimated completion is 2010-08.

What interventions are being tested in trial NCT00222937?

The interventions under investigation include: Lessac-Madsen Resonant Voice Therapy (BEHAVIORAL), Casper-Based Confidential Flow Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00222937?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.